DD283771A5 - Verfahren zur herstellung einer peroralen praeparation einer saeure-instabilen verbindung - Google Patents

Verfahren zur herstellung einer peroralen praeparation einer saeure-instabilen verbindung Download PDF

Info

Publication number
DD283771A5
DD283771A5 DD89328639A DD32863989A DD283771A5 DD 283771 A5 DD283771 A5 DD 283771A5 DD 89328639 A DD89328639 A DD 89328639A DD 32863989 A DD32863989 A DD 32863989A DD 283771 A5 DD283771 A5 DD 283771A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
compound
prepared
coated
tablets
Prior art date
Application number
DD89328639A
Other languages
German (de)
English (en)
Inventor
Yasuharu Saeki
Noritoshi Koyama
Sumio Watanabe
Shigeru Aoki
Original Assignee
�����@�K�K�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@�K�K�Kk�� filed Critical �����@�K�K�Kk��
Publication of DD283771A5 publication Critical patent/DD283771A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
DD89328639A 1988-05-18 1989-05-16 Verfahren zur herstellung einer peroralen praeparation einer saeure-instabilen verbindung DD283771A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63121233A JPH0768125B2 (ja) 1988-05-18 1988-05-18 酸不安定化合物の内服用製剤

Publications (1)

Publication Number Publication Date
DD283771A5 true DD283771A5 (de) 1990-10-24

Family

ID=14806208

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89328639A DD283771A5 (de) 1988-05-18 1989-05-16 Verfahren zur herstellung einer peroralen praeparation einer saeure-instabilen verbindung

Country Status (14)

Country Link
US (1) US5035899A (fr)
EP (1) EP0342522B1 (fr)
JP (1) JPH0768125B2 (fr)
KR (1) KR910002641B1 (fr)
AT (1) ATE70442T1 (fr)
CA (1) CA1336958C (fr)
DD (1) DD283771A5 (fr)
DE (1) DE68900566D1 (fr)
DK (1) DK174664B1 (fr)
ES (1) ES2051919T3 (fr)
FI (1) FI93422C (fr)
GR (1) GR3003389T3 (fr)
HU (1) HU203200B (fr)
NO (1) NO178135C (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
DE69327745T2 (de) * 1992-05-29 2000-09-21 Nikken Chemicals Co Ltd Tablette zur langsamen Freisetzung von Natriumvalproat
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
MX9700152A (es) * 1994-07-08 1997-04-30 Astra Ab Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol.
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
FR2774288B1 (fr) 1998-01-30 2001-09-07 Ethypharm Sa Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
WO1999055158A1 (fr) * 1998-04-30 1999-11-04 Sepracor Inc. Compositions a base de s-rabeprazole et procedes
US6174902B1 (en) 1999-04-28 2001-01-16 Sepracor Inc. R-rabeprazole compositions and methods
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
CA2376202C (fr) 1999-06-07 2008-11-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparation et forme galenique comprenant un compose actif acido-labile
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20020064555A1 (en) * 2000-09-29 2002-05-30 Dan Cullen Proton pump inhibitor formulation
JP2002234842A (ja) * 2001-02-09 2002-08-23 Kyowa Yakuhin Kogyo Kk 内服腸溶性製剤
IL157634A0 (en) * 2001-03-13 2004-03-28 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms containing glucocorticosteroid
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US20050163846A1 (en) * 2001-11-21 2005-07-28 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound, and process for producing same
DE10211289A1 (de) * 2002-03-14 2003-09-25 Basf Ag Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040028737A1 (en) * 2002-08-12 2004-02-12 Kopran Research Laboratories Limited Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
JP2004231520A (ja) * 2003-01-28 2004-08-19 Nichiko Pharmaceutical Co Ltd 保存安定性及び溶出速度に優れた医薬組成物
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20050147663A1 (en) * 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
WO2005025544A1 (fr) * 2003-09-11 2005-03-24 Glykon Technologies Group, Llc Administration enterique d'acide (-)-hydroxycitrique
MXPA06003101A (es) * 2003-09-19 2006-06-20 Penwest Pharmaceuticals Co Formas de dosis cronoterapeuticas.
BRPI0414311A (pt) * 2003-09-19 2008-03-04 Penwest Pharmaceutical Co formas de dosagem de liberação controlada
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
WO2005051362A2 (fr) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Compositions stables de benzimidazole a administration orale et leurs procedes de preparation
EP1699458A4 (fr) * 2003-12-30 2012-04-25 Reddys Lab Ltd Dr Composition pharmaceutique
CN1938026A (zh) * 2004-03-26 2007-03-28 卫材R&D管理有限公司 控释制剂及其制造方法
US20050239845A1 (en) * 2004-04-16 2005-10-27 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
CA2592605C (fr) * 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Methode de stabilisation d'un medicament contre la demence
US20090208575A1 (en) * 2005-01-03 2009-08-20 Lupin Limited Pharmaceutical Composition Of Acid Labile Substances
CN101375534B (zh) * 2005-06-29 2012-03-21 美国亚德诺半导体公司 用于音频设备的改进的充/放电控制电路
JPWO2007037259A1 (ja) * 2005-09-29 2009-04-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 生体内での崩壊性を向上させたパルス製剤
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
BRPI0621024A2 (pt) * 2006-01-16 2011-11-29 Jubilant Organosys Ltd formulação farmacêutica estável de um composto de ácido lábil e o processo para preparação do mesmo
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2068841B1 (fr) 2006-10-05 2018-09-26 Santarus, Inc. Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations
WO2008062320A2 (fr) * 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Formulations à libération prolongée d'un inhibiteur de la pompe à protons
WO2008057802A2 (fr) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation
WO2009069280A1 (fr) 2007-11-27 2009-06-04 Ohara Pharmaceutical Co., Ltd. Procédé de production d'une substance granulée
SI22806A (sl) * 2008-06-23 2009-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalinične oblike natrijevega rabeprazola
CH699302B1 (de) * 2008-08-11 2012-03-15 Mepha Gmbh Orale pharmazeutische Formulierung für Omeprazol, enthaltend eine spezifische Trennschicht.
EP2344139A1 (fr) * 2008-09-09 2011-07-20 AstraZeneca AB Procédé d'administration d'une composition pharmaceutique à un patient en ayant besoin
WO2010042785A1 (fr) * 2008-10-10 2010-04-15 Celtaxsys, Inc. Procédé d’induction d’un chimiotactisme négatif
US20110008432A1 (en) * 2009-06-25 2011-01-13 Pozen Inc. Method for Treating a Patient in Need of Aspirin Therapy
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
CN102805733B (zh) * 2011-06-01 2016-03-09 日东电工株式会社 颗粒制剂及其制造方法
US20140328861A1 (en) 2011-12-16 2014-11-06 Atopix Therapeutics Limited Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
US9233074B2 (en) * 2013-03-01 2016-01-12 Bpsi Holdings, Llc Delayed release film coatings containing calcium silicate and substrates coated therewith
JP6344678B2 (ja) * 2013-09-27 2018-06-20 キョーリンリメディオ株式会社 テルミサルタン含有製剤及びその製造方法
WO2024075017A1 (fr) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition de calcification de valve aortique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi

Also Published As

Publication number Publication date
FI93422C (fi) 1995-04-10
DE68900566D1 (de) 1992-01-30
CA1336958C (fr) 1995-09-12
NO891935D0 (no) 1989-05-12
ATE70442T1 (de) 1992-01-15
HUT51896A (en) 1990-06-28
FI891650A0 (fi) 1989-04-06
DK239189D0 (da) 1989-05-17
DK239189A (da) 1989-11-19
JPH0768125B2 (ja) 1995-07-26
KR910002641B1 (ko) 1991-04-27
JPH01290628A (ja) 1989-11-22
DK174664B1 (da) 2003-08-18
US5035899A (en) 1991-07-30
KR890016964A (ko) 1989-12-14
NO891935L (no) 1989-11-20
HU203200B (en) 1991-06-28
EP0342522B1 (fr) 1991-12-18
FI891650A (fi) 1989-11-19
NO178135B (no) 1995-10-23
NO178135C (no) 1996-01-31
GR3003389T3 (en) 1993-02-17
ES2051919T3 (es) 1994-07-01
FI93422B (fi) 1994-12-30
EP0342522A1 (fr) 1989-11-23

Similar Documents

Publication Publication Date Title
DD283771A5 (de) Verfahren zur herstellung einer peroralen praeparation einer saeure-instabilen verbindung
DE69631834T2 (de) Neues ein säureempfindliches benzimidazol enthaltendes mittel und verfahren zu dessen herstellung
DE69721845T2 (de) Orale morphinzubereitung in teilchenform
EP0078430B2 (fr) Procédé de fabrication de préparations pharmaceutiques solides à libération rapide de dihydropyridines
DE3915150C2 (de) Lang-wirkendes Diclofenac-Natrium-Präparat
DE60029712T2 (de) Feste oral anzuwendende Arzneizubereitung mit gesteuerter Wirkstoffabgabe enthaltend eine säureempfindliche Benzimidazolverbindung
DE60100186T2 (de) Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung
DE69729950T2 (de) Arzneimittel-Zuführsystem mit verzögerter Freisetzung für säurelabile Arzneistoffe
CH648484A5 (de) Pharmazeutische zubereitung eines festen medikamentmaterials.
DE60038447T2 (de) Stabile benzimidazol zusammensetzungen
EP0934058B1 (fr) Forme stable de medicament pour administration par voie orale, a base de derives de benzimidazole comme principe actif, et son procede de productionn
DE10209982A1 (de) Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
DD260222B5 (de) Verfahren zur Herstellung eines oralen pharmazeutischen Praeparates das eine saeureunbestaendige Verbindung enthaelt
DE60036014T2 (de) Methode zur stabilisierung von benzimidazol-verbindungen
EP1485094A1 (fr) FORME DE PRESENTATION A ADMINISTRER PAR VOIE ORALE POUR L'ETHYLESTER D'ACIDE 3- (2- 4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO]-METHYL -1-METHYL-1 i H /i -BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO]-PROPIONIQUE ET SES SELS
DD298205A5 (de) Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
DE102008046650A1 (de) Quetiapin enthaltende Retardtablette
EP0439030A2 (fr) Formes d'administration orale contenant du pimobendane
DE69916876T2 (de) Umhüllte teilchen bestehend aus kristallisiertem granuliertem ibuprofen
DE60114887T2 (de) Partikuläre zusammensetzung mit sigmoidem freisetzungsmuster enthaltend eletriptan hydrobromid
EP0378137A2 (fr) Forme galénique
DE60035579T2 (de) Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
AT400519B (de) Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung
DE3419128A1 (de) Dihydropyridinpraeparate und verfahren zu ihrer herstellung
DE3419131A1 (de) Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20090517